Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use with Nitrate Prescription Order Form:Ciprofloxacin
Tizanidine may cause significant vomiting, diarrhea, chesjeevax, dizziness, nausea, fatigue, vomiting blood in the urine, chest pain, palpitations, tachycardia, hypotension, respiratory failure, skin rash, skin irritation, muscle weakness, and dizziness. In vitro studies have shown that a small dosage increase in molar dosage (e.g. 20 mg/L) does not increase tardive dyskinesia (extrapyramide partial sedative effects). In rheumatoid arthritis, systemic use of the medication may also lead to QT prolongation. For example, in a recent study, the QTc interval of patients with anR rheumatoid arthritis treated with the oral quinolone antibiotic ciprofloxacin was reduced from 8.8 to 3.1 milliseconds, compared to that of the control group. Other studies have shown no difference in the incidence of developing QT prolongation in the rheumatoid arthritis population. However, in a study of patients with rheumatoid arthritis who are receiving chronic oral quinolone antibiotic therapy, a mean increase of 16 msec in the tQUETIAPINErheumatoid arthritis population was observed, compared with a mean increase of 5.4 msec in the control group. The mean trheumatoid arthritis incidence of the patients receiving chronic oral quinolone antibiotic therapy was 6.3 msec, compared with 3.6 msec in the group receiving no treatment. No significant changes in the electrocardiogram, electro-oculogram, or electro-oxidometry parameters were observed. However, the electro-oculometric parameters showed a reduction in QTc interval, mean energy expenditure, and a mean reduction in QT-clock time. Therefore, the off-target effects of molar dosage reduction are unlikely to be a significant problem. However, off-target effects of molar dosage reduction are possible, possibly by affecting serum potassium levels, resulting in hyperkalaemia and even severe hypokalaemia. Hyperkalaemia with molar dosage reduction has been reported in some patients.
Ciprofloxacin, commonly known by the brand name Cipro, is an antibiotic medication that belongs to the fluoroquinolone class. It is frequently prescribed for the treatment of various bacterial infections in humans. While Cipro is commonly used for humans, it can also be prescribed for certain types of bacterial infections in pets.
When it comes to using Ciprofloxacin or any other medication for pets, it is crucial to consult with a veterinarian. Veterinarians are best equipped to determine the appropriate medications, dosages, and treatment plans based on the specific needs of the animal.
Using human medications for pets without veterinary guidance can be risky. Animals may have different physiological characteristics, metabolize drugs differently, and require specific dosages based on their size, species, and condition. Additionally, some medications can be toxic to certain animals.
Therefore, if your pet requires treatment with Ciprofloxacin or any other medication, it is essential to seek veterinary advice. A veterinarian will be able to assess your pet's condition, perform any necessary diagnostic tests, and provide appropriate treatment recommendations, including medication options that are safe and effective for your pet's specific situation.
Remember, always consult with a veterinarian to ensure the health and well-being of your pet. They are the best resource for determining the appropriate medications and treatment options for your pet's specific needs.
Ciprofloxacin (Phryno spp.) Ciprofloxacin (Phryno spp.)Ciprofloxacin (Phryno spp.) (brand name Cipro) Generic Name: Ciprofloxacin
Cautions
Patients with cardiovascular disease, liver disease, thyroid disease, thyroiditis, psychiatric disorders, or severe kidney disease should not use Ciprofloxacin. Ciprofloxacin can also affect the liver and affect the metabolism of some medications. If your pet has any of the following conditions, contact a veterinarian immediately:
Ciprofloxacin should not be given to pets with certain food intolerances. Pets with dairy or calcium-containing supplements should not use Ciprofloxacin. Dogs and Cats should avoid using Ciprofloxacin due to its potential to cause an increase in drug levels in the urine.
Ciprofloxacin should not be given to pets with certain other serious medical conditions. Pets with liver disease, diabetes, thyroid disease, seizures, liver tumors, or kidney or heart problems should consult with a veterinarian before using Ciprofloxacin.
Ciprofloxacin can cause side effects in some animals. Common side effects of Ciprofloxacin (Phryno spp.) are vomiting, diarrhea, and an increased appetite. Rarely, cats, dogs, and small dogs have died. Signs and symptoms of liver problems, including nausea, vomiting, lethargy, and abdominal pain, should be reported to a veterinarian immediately.
Treatment of bacterial infections of the lungs, nose, ear, bones and joints, skin and soft tissue, kidney, bladder, abdomen, and genitals caused by ciprofloxacin-susceptible organisms. Infections may include urinary tract infection, prostatitis, lower respiratory tract infection, otitis media (middle ear infection), sinusitis, skin, bone and joint infections, infectious diarrhea, typhoid fever, and gonorrhea.
May be taken with or without food. May be taken w/ meals to minimise GI discomfort. Do not take w/ antacids, Fe or dairy products.
Hypersensitivity to ciprofloxacin or other quinolones. History or risk of QT prolongation; known history of myasthenia gravis. Concomitant use with tizanidine.
Vomiting, Stomach pain, Nausea, Diarrhea
Patient with known or suspected CNS disorders, risk factors predisposing to seizures, or lower seizure threshold; history or risk factors for QT interval prolongation, torsades de pointes, uncorrected hypokalaemia/hypomagnesaemia, cardiac disease (e.g. heart failure, MI, bradycardia); positive family history of aneurysm disease, pre-existing aortic aneurysm or dissection and its risk factors (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, hypertension, peripheral atherosclerotic vascular disease); diabetes, previous tendon disorder (e.g. rheumatoid arthritis), G6PD deficiency. Renal and hepatic impairment. Elderly, children. Pregnancy and lactation.
Store between 20-25°C.
Quinolones
Use on meds go (high).MedsGo contraindications. Avoid medsquinolones with high risk of QT interval prolonging (or QTc prolongation), from proton pump inhibitors (PPIs) to bisphosphonates (Proton Pump Inhibitors).
Ciprofloxacin Tablets USP 500 mg (Ciprofloxacin) 5 times dailyUse on meds goSee MedsGo for contraindication requirements and uses. Caution in renal impairment.
Severe dizziness, fainting.
MedsGo contraindication. Avoid medsquinolones with high risk of QT interval prolonging (or QTc prolongation), from PPI to PPI bisphosphonates.
Tizanidine Potassium 25 mg (Tizanidine) 5 times dailyPrevention of QT interval prolongation, from PPI to PPI bisphosphonatesMedsGo contraindication.
Hypertension
Care for newborns, elderly patients, children, post-surgical patients and infectious diseases.